Previous 10 | Next 10 |
2023-08-21 09:23:00 ET Wall Street analysts are upbeat on California-based biotech Illumina (NASDAQ: ILMN) these days, estimating on average that the stock could climb by up to 27% over the next year. But without some serious and unexpected new developments, that composite estimate ...
2023-08-17 14:28:04 ET Illumina, Inc. (ILMN) UBS MedTech, Tools and Genomics Summit 2023 Conference Transcript August 17, 2023, 12:00 PM ET Executives Salli Schwartz - Vice President, Investor Relations Analysts John Sourbeer - UBS Presentation ...
Illumina expands genomics capabilities in India with opening of Solutions Center PR Newswire SAN DIEGO , Aug. 17, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the opening of a n...
2023-08-17 06:55:00 ET Illumina 's (NASDAQ: ILMN) stock is down by 15% this year so far, and it's no surprise why. With the new disclosure of a Securities and Exchange Commission (SEC) investigation into its bedraggled acquisition of Grail, a genetic-testing company it originally fo...
2023-08-16 01:39:00 ET Summary Q2 was a resilient quarter on the earnings front (again) which saw both a beat rate and an earnings surprise rate reaching a multi-quarter high. The ‘Magnificent-7’ saw Q2 earnings of $67.1 billion (+38.5% y/y, +11.4 q/q). All thing...
2023-08-14 07:37:12 ET Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Spotify . For further details see: Wall Street Breakfast: AI Generation
2023-08-11 13:30:00 ET Summary Total IEP units outstanding increased by over 10% in the second quarter alone, contributing to a further decrease in IEP's Net Asset Value (NAV) per unit. This occurred despite an increasing number of outside investors, almost 70%, taking distributio...
2023-08-10 00:08:08 ET Illumina, Inc. (ILMN) Q2 2023 Results Earnings Conference Call August 9, 2023, 05:00 PM ET Company Participants Salli Schwartz - Vice President of Investor Relations Charles Dadswell - Interim Chief Executive Officer and General Counsel Joy...
2023-08-09 16:46:25 ET Shares of Illumina ( NASDAQ: ILMN ) on Wednesday shed more than 5% in extended trading, after the genetic sequencing and testing company slashed its full year guidance despite shipping more sequencing instruments in Q2. ILMN stock was down 5.8% to $173.79 ...
Dr. Steven Barnard Appointed Chief Technology Officer PR Newswire SAN DIEGO , Aug. 9, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Dr. Steven Barnard , Illumina's Vice Pres...
News, Short Squeeze, Breakout and More Instantly...
Illumina to Present Upcoming Strategy Update PR Newswire SAN DIEGO , July 18, 2024 /PRNewswire/ -- As Illumina, Inc. (NASDAQ: ILMN) previously announced on June 24 , the company will present a Strategy Update on Tuesday, August 13, 2024 starting at ...
Illumina to Announce Second Quarter 2024 Financial Results on Tuesday, August 6, 2024 PR Newswire SAN DIEGO , July 11, 2024 /PRNewswire/ -- As Illumina, Inc. (NASDAQ:ILMN) previously announced on June 24 , the company will issue results for the second qu...
The Illumina iHope China program will provide 1800 families with genetic testing in 2024, broadening its reach and impact nationwide Originally published on Illumina News Center NORTHAMPTON, MA / ACCESSWIRE / July 11, 2024 / This year may be the most impactful yet in the short history o...